GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLB Pharmaceutical Co Ltd (XKRX:047920) » Definitions » Price-to-Operating-Cash-Flow

HLB Pharmaceutical Co (XKRX:047920) Price-to-Operating-Cash-Flow : 246.10 (As of Jun. 05, 2025)


View and export this data going back to 2015. Start your Free Trial

What is HLB Pharmaceutical Co Price-to-Operating-Cash-Flow?

As of today (2025-06-05), HLB Pharmaceutical Co's share price is ₩18790.00. HLB Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩76.35. Hence, HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow Ratio for today is 246.10.

The historical rank and industry rank for HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

XKRX:047920' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 31.36   Med: 170.16   Max: 596.07
Current: 246.1

During the past 11 years, HLB Pharmaceutical Co's highest Price-to-Operating-Cash-Flow Ratio was 596.07. The lowest was 31.36. And the median was 170.16.

XKRX:047920's Price-to-Operating-Cash-Flow is ranked worse than
97.38% of 688 companies
in the Drug Manufacturers industry
Industry Median: 17.465 vs XKRX:047920: 246.10

HLB Pharmaceutical Co's Cash Flow from Operations per share for the three months ended in Mar. 2025 was ₩-33.57. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩76.35.

During the past 11 years, HLB Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.00% per year. The lowest was -190.80% per year. And the median was 4.65% per year.


HLB Pharmaceutical Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Pharmaceutical Co Price-to-Operating-Cash-Flow Chart

HLB Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 112.94

HLB Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 174.20 112.94 263.25

Competitive Comparison of HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.


;
;

HLB Pharmaceutical Co Price-to-Operating-Cash-Flow Calculation

HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=18790.00/76.352
=246.10

HLB Pharmaceutical Co's Share Price of today is ₩18790.00.
HLB Pharmaceutical Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩76.35.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

HLB Pharmaceutical Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of HLB Pharmaceutical Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
67, Euiui-ro, Songpa-gu, MK Tower 9th Floor, Seoul, KOR
HLB Pharmaceutical Co Ltd is a research-oriented pharmaceutical company. It is engaged in developing medicines and drugs. Its products include skeletal muscle relaxant, pain relief drugs, blood pressure-lowering agents, local anaesthetics, digestive system drugs, antacids, vitamins, haemorrhoid solvents, insect repellents, peptic ulcer solvents, and other products.

HLB Pharmaceutical Co Headlines

No Headlines